SCHEMBL132015

SCHEMBL132015

[c]1ncnc2nc[nH]c12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4920480 0.67
SCHEMBL2867175 0.64 ALDH1A1 (0.46)
SCHEMBL2875131 0.64 KDM4E (0.46)
SCHEMBL9045356 0.64 ALDH1A1 (0.30)
SCHEMBL132014 0.64
SCHEMBL9582 0.64
SCHEMBL7491987 0.60 CDK1 (0.33)
SCHEMBL838220 0.58
SCHEMBL940153 0.57
Purine SCHEMBL30862524 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 925 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11993590-B2 Pyranone compounds useful to modulate OMA1 protease 712 NORTH INC. (US) 2024-05-28 US claimed
US-20230321049-A1 COMPOSITIONS OF ENPP1 INHIBITORS AND USES THEREOF Petragen, Inc. 2023-10-12 US claimed
WO-2023107490-A1 HETEROCYCLE-CONTAINING LONP1 INHIBITOR COMPOUNDS, USES AND METHODS PRETZEL THERAPEUTICS, INC. (US) 2023-06-15 WO claimed
US-20210246125-A1 PYRANONE COMPOUNDS USEFUL TO MODULATE OMA1 PROTEASE 712 NORTH INC. 2021-08-12 US claimed
CN-111320630-A Compound with TNF- α inhibitory activity and application 武汉华杰世纪生物医药有限公司 2020-06-23 CN claimed
CN-110669058-A Tricyclic quinolone carboxylic acid and preparation method thereof 江西农业大学 2020-01-10 CN claimed
US-10294260-B2 Tetracyclic anthraquinone derivatives TIANJIN HEMAY ONCOLOGY PHARMACEUTICAL CO., LTD. (CN) 2019-05-21 US claimed
EP-3283481-B1 CHROMENE DERIVATIVES AS PHOSHOINOSITIDE 3-KINASES INHIBITORS CHIESI FARM SPA (IT) 2019-03-13 EP claimed
US-10179790-B2 MTH1 inhibitors for treatment of cancer THOMAS HELLEDAYS STIFTELSE FOR MEDICINSK FORSKNING (SE) 2019-01-15 US claimed
US-9968604-B2 Chromene derivatives as phoshoinositide 3-kinases inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2018-05-15 US claimed
EP-0154528-B1 ALKENE, ALKYNE OR CYCLOALKYLENE DERIVATIVES IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1991-12-11 EP claimed
EP-0421600-A1 Asymmetric chemical synthesis and intermediates for making antifungal compounds SCHERING CORPORATION (US) 1991-04-10 EP claimed
WO-1991003473-A1 THREONINE DERIVED ASYMMETRIC CHEMICAL SYNTHESIS AND INTERMEDIATES FOR MAKING ANTIFUNGAL COMPOUNDS SCHERING CORPORATION (US) 1991-03-21 WO claimed
WO-1991003451-A1 ASYMMETRIC CHEMICAL SYNTHESIS AND INTERMEDIATES FOR MAKING ANTIFUNGAL COMPOUNDS SCHERING CORPORATION (US) 1991-03-21 WO claimed
EP-0415748-A1 Threonine derived asymmetric chemical synthesis and intermediates for making antifungal compounds SCHERING CORPORATION (US) 1991-03-06 EP claimed
US-4956369-A HYPOTENSIVE AGENTS BOEHRINGER BIOCHEMIA ROBIN S.P.A. (IT) 1990-09-11 US claimed
US-4873329-A ANTIANDROGENS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1989-10-10 US claimed
EP-0301422-A2 Thiomethyl and sulfinylmethyl derivatives having gastric acid antisecretory activity, processes for the preparation thereof and pharmaceutical compositions containing them CHIESI FARMACEUTICI S.p.A. (IT) 1989-02-01 EP claimed
EP-0214479-A2 Benzimidazol-2-ylpyridinium compounds F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1987-03-18 EP claimed
EP-0154528-A2 Alkene, alkyne or cycloalkylene derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1985-09-11 EP claimed